Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'

被引：16

作者：

Brennan, Donal J. ^{[1
]}

Gallagher, William M. ^{[1
]}

机构：

[1] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland

来源：

BREAST CANCER RESEARCH | 2008年 / 10卷 / 01期

关键词：

D O I：

10.1186/bcr1854

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

An urgent requirement exists for new prognostic and predictive assays in breast cancer. Despite the development of high-throughput technologies such as DNA microarrays, it would now appear that immunohistochemistry ( IHC) may play an increasingly important role in the clinical management of breast cancer. In this editorial, the authors discuss the potential prognostic ability of a panel of IHC markers, and question whether this well-established assay technology may in fact allow for improved prognostic and predictive tests in breast cancer.

引用

页数：3

共 13 条

[1] Analysis of protein expression in cell microarrays:: A tool for antibody-based proteomics [J].

Andersson, Ann-Catrin ;

Stromberg, Sara ;

Backvall, Helena ;

Kampf, Caroline ;

Uhlen, Mathias ;

Wester, Kenneth ;

Ponten, Fredrik .

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2006, 54 (12) :1413-1423

[2] Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative [J].

Bossuyt, PM ;

Reitsma, JB ;

Bruns, DE ;

Gatsonis, CA ;

Glasziou, PP ;

Irwig, LM ;

Lijmer, JG ;

Moher, D ;

Rennie, D ;

de Vet, HCW .

ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) :40-44

[3] Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response [J].

Brennan, DJ ;

O'Brien, SL ;

Fagan, A ;

Culhane, AC ;

Higgins, DG ;

Duffy, MJ ;

Gallagher, WM .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (08) :1069-1083

[4]

BRENNAN DJ, 2007, CANCER GENOM PROTEOM, V4, P3

[5] Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].

Carey, Lisa A. ;

Perou, Charles M. ;

Livasy, Chad A. ;

Dressler, Lynn G. ;

Cowan, David ;

Conway, Kathleen ;

Karaca, Gamze ;

Troester, Melissa A. ;

Tse, Chiu Kit ;

Edmiston, Sharon ;

Deming, Sandra L. ;

Geradts, Joseph ;

Cheang, Maggie C. U. ;

Nielsen, Torsten O. ;

Moorman, Patricia G. ;

Earp, H. Shelton ;

Millikan, Robert C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502

[6]

Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P

[7] Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study [J].

Crabb, Simon J. ;

Bajdik, Chris D. ;

Leung, Samuel ;

Speers, Caroline H. ;

Kennecke, Hagen ;

Huntsman, David G. ;

Gelmon, Karen A. .

BREAST CANCER RESEARCH, 2008, 10 (01)

[8] Concordance among gene-expression-based predictors for breast cancer [J].

Fan, Cheng ;

Oh, Daniel S. ;

Wessels, Lodewyk ;

Weigelt, Britta ;

Nuyten, Dimitry S. A. ;

Nobel, Andrew B. ;

van't Veer, Laura J. ;

Perou, Charles M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (06) :560-569

[9] Meeting highlights:: Updated international expert consensus on the primary therapy of early breast cancer [J].

Goldhirsch, A ;

Wood, WC ;

Gelber, RD ;

Coates, AS ;

Thürlimann, B ;

Senn, HJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3357-3365

[10]

Kampf C., 2004, CLIN PROTEOM, V1, P285, DOI DOI 10.1385/CP:1:3-4:285

← 1 2 →